Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Virtual reality could revolutionize heart rehab

NCT ID NCT07095504

Symptom relief Sponsor: Mayo Clinic Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jul 31, 2026 · Updated 1 time

Summary

This study tests whether a virtual world-based cardiac rehabilitation program is feasible for heart patients. Five participants will attend 24 online sessions over 8 weeks, including video visits with exercise physiologists and nurse coaches, plus group education. The goal is to see if this approach can improve cardiovascular health and reduce hospital readmissions.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Virtual world-based cardiac rehabilitation program
What this could lead to
If successful, this could provide a convenient, home-based option for cardiac rehabilitation, potentially improving heart health and reducing hospital visits.
What could go wrong
This is a very small feasibility study with only 5 participants, so results may not apply to larger groups. The virtual format may not suit everyone, and long-term benefits are unknown.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

8 people

The number who actually took part.

Started

Dec 2025

Finished

Jun 2026

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Indication for CR according to Centers for Medicare \& Medicaid Services (CMS) guidelines (diagnosed within the preceding 12 months) to include one or more of the following: * Myocardial infarction * Coronary artery bypass surgery * Current stable angina (chest pain) * Heart valve repair or replacement * Percutaneous transluminal coronary angioplasty (PTCA) or coronary stenting * Heart or heart-lung transplant * Stable chronic heart failure * Receiving care at one of the participating CR centers * Age ≥18 years * Basic Internet navigation skills * Active email address * Access to Internet at home or public access (church, library, etc) for 3 virtual visits per week Exclusion Criteria: * High risk patients according to the AACVPR risk stratification44 given safety concern of unsupervised exercise * Patients receiving continuous inotropic support * Recent receipt of a mechanical support device * Presence of hemodynamically unstable dysrhythmias (e.g., ventricular tachycardia) * Decompensated heart failure * Symptomatic valvular heart disease * Uncontrolled angina * Pregnancy (due to associated hormonal and weight changes) per patient report * Receiving continuous inotropic support * Presence of a mechanical circulatory support device * Decompensated heart failure * Symptomatic valvular heart disease * Uncontrolled angina * Presence of hemodynamically unstable dysrhythmias (e.g., ventricular tachycardia) given safety concern of unsupervised exercise * Visual/hearing impairment or mental disability that would preclude independent use of the VW platform * Non-English-speaking patients due to logistical challenges with real time translation over a virtual platform * Currently participating in a cardiac rehab program

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Cardiovascular health are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

heart failure myocardial infarction

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Cardiovascular health

Contacts and locations

Locations

  • Mayo Clinic

    Jacksonville, Florida, 32224, United States

  • Mayo Clinic

    Rochester, Minnesota, 55905, United States

  • University of California (UCI), Irvine

    Irvine, California, 92617, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.